194 related articles for article (PubMed ID: 34796976)
1. Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
Janzen A; Kogan RV; Meles SK; Sittig E; Renken RJ; Geibl FF; Booij J; Stormezand G; Luster M; Mayer G; Leenders KL; Oertel WH
Mov Disord; 2022 Mar; 37(3):624-629. PubMed ID: 34796976
[TBL] [Abstract][Full Text] [Related]
2. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
[TBL] [Abstract][Full Text] [Related]
3. Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder.
Carli G; Meles SK; Janzen A; Sittig E; Kogan RV; Perani D; Oertel WH; Leenders KL;
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3290-3301. PubMed ID: 37310428
[TBL] [Abstract][Full Text] [Related]
4. Four-Year Follow-up of [
Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
[TBL] [Abstract][Full Text] [Related]
5. Dual-phase
Kim MS; Park DG; An YS; Yoon JH
Eur J Neurol; 2023 Feb; 30(2):344-352. PubMed ID: 36288409
[TBL] [Abstract][Full Text] [Related]
6. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.
Nishikawa N; Murata M; Hatano T; Mukai Y; Saitoh Y; Sakamoto T; Hanakawa T; Kamei Y; Tachimori H; Hatano K; Matsuda H; Taruno Y; Sawamoto N; Kajiyama Y; Ikenaka K; Kawabata K; Nakamura T; Iwaki H; Kadotani H; Sumi Y; Inoue Y; Hayashi T; Ikeuchi T; Shimo Y; Mochizuki H; Watanabe H; Hattori N; Takahashi Y; Takahashi R;
Parkinsonism Relat Disord; 2022 Oct; 103():129-135. PubMed ID: 36113390
[TBL] [Abstract][Full Text] [Related]
8. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.
Meles SK; Renken RJ; Janzen A; Vadasz D; Pagani M; Arnaldi D; Morbelli S; Nobili F; Mayer G; Leenders KL; Oertel WH;
J Nucl Med; 2018 Sep; 59(9):1437-1444. PubMed ID: 29476004
[TBL] [Abstract][Full Text] [Related]
9. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
10. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
[TBL] [Abstract][Full Text] [Related]
11. Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder.
Ganapathy S R; Levová K; Kotačková L; Trnka J; Zogala D; Rusz J; Zima T; Devos D; Šonka K; Růžička E; Kalousová M; Dušek P
Mov Disord; 2022 May; 37(5):983-992. PubMed ID: 35128728
[TBL] [Abstract][Full Text] [Related]
12. Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder.
Huang Z; Jiang C; Li L; Xu Q; Ge J; Li M; Guan Y; Wu J; Wang J; Zuo C; Yu H; Wu P
J Cereb Blood Flow Metab; 2020 Mar; 40(3):552-562. PubMed ID: 30741074
[TBL] [Abstract][Full Text] [Related]
13. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
[TBL] [Abstract][Full Text] [Related]
14. Dysprosody in Isolated REM Sleep Behavior Disorder with Impaired Olfaction but Intact Nigrostriatal Pathway.
Rusz J; Janzen A; Tykalová T; Novotný M; Zogala D; Timmermann L; Růžička E; Šonka K; Dušek P; Oertel W
Mov Disord; 2022 Mar; 37(3):619-623. PubMed ID: 34837250
[TBL] [Abstract][Full Text] [Related]
15. Brain Metabolic Correlates of Dopaminergic Denervation in Prodromal and Early Parkinson's Disease.
Kim R; Kim H; Kim YK; Yoon EJ; Nam HW; Jeon B; Lee JY
Mov Disord; 2022 Oct; 37(10):2099-2109. PubMed ID: 36250497
[TBL] [Abstract][Full Text] [Related]
16. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
Zoetmulder M; Nikolic M; Biernat H; Korbo L; Friberg L; Jennum P
J Clin Sleep Med; 2016 Jun; 12(6):895-903. PubMed ID: 27070245
[TBL] [Abstract][Full Text] [Related]
17. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
[TBL] [Abstract][Full Text] [Related]
18. Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease.
Rus T; Schindlbeck KA; Tang CC; Vo A; Dhawan V; Trošt M; Eidelberg D
Mov Disord; 2022 Nov; 37(11):2247-2256. PubMed ID: 36054380
[TBL] [Abstract][Full Text] [Related]
19. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
[TBL] [Abstract][Full Text] [Related]
20. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
